Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06626139 · ClinicalTrials.gov registry record · Phase 2
Investigating the Interaction of Psilocybin and Context of Its Administration in Healthy Volunteers
A Phase 2 study of Healthy Participants With Lower-than-average Mental Well-being, sponsored by Robin Carhart-Harris, PhD, MA.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT06626139 is a Phase 2 study of Healthy Participants With Lower-than-average Mental Well-being that is actively recruiting participants, run by Robin Carhart-Harris, PhD, MA. The registered enrollment target is 120 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06626139, a Phase 2 study of Healthy Participants With Lower-than-average Mental Well-being, is actively recruiting participants, sponsored by Robin Carhart-Harris, PhD, MA.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
One hundred twenty healthy participants, ages 21 to 70, who experience moderate-to-lower-than-average mental well-being will be evenly randomized into four different study arms, using a 2x2 factorial design. Depending on the study arm, participants will either receive an inactive placebo or up to 25mg psilocybin (oral dose), in one of two set and setting conditions; drug administration contexts that are predicted to modulate drug effects. The purpose of this study is to evaluate any interaction effects between an oral dose of psilocybin and the surrounding context (set and setting).
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Psilocybin
- BEHAVIORAL Context 1
- BEHAVIORAL Context 2
Study Locations (1)
California
- UCSF Mission Bay - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2024-10-20 |
| Est. Completion | 2028-11-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06626139
The ClinicalTrials.gov registry entry for NCT06626139 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Robin Carhart-Harris, PhD, MA, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy Participants With Lower-than-average Mental Well-being appearing as the primary indexed condition, and to 4 interventions - of which Placebo is the first listed.
NCT06626139 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06626139 about?
NCT06626139 is a clinical study titled "Investigating the Interaction of Psilocybin and Context of Its Administration in Healthy Volunteers". One hundred twenty healthy participants, ages 21 to 70, who experience moderate-to-lower-than-average mental well-being will be evenly randomized into four different study arms, using a 2x2 factorial design. Depending on the study arm, participants will either receive an inactive placebo or up to 25...
What is the current status of trial NCT06626139?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 120 participants. The study started on 2024-10-20. Estimated completion is 2028-11-30.
What conditions does trial NCT06626139 study?
This clinical trial studies the following conditions: Healthy Participants With Lower-than-average Mental Well-being.
What interventions are being tested in trial NCT06626139?
The interventions under investigation include: Placebo (DRUG), Psilocybin (DRUG), Context 1 (BEHAVIORAL), Context 2 (BEHAVIORAL).
Who is sponsoring clinical trial NCT06626139?
This trial is sponsored by Robin Carhart-Harris, PhD, MA, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06626139 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.